Clinical Trial Update: A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 rheumatoid arthritis trial in patients already receiving methotrexate, sponsored by Amgen, has completed. This document provides an update on the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED